Icon plc Stock
Price
Target price
€143.80
€143.80
0.030%
0.05
0.030%
€254.64
09:34 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
With only a change of €0.050 (0.030%) the Icon plc price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 34 Buy predictions and no Sell predictions.
As a result the target price of 254 € shows a very positive potential of 76.63% compared to the current price of 143.8 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.030% | -9.761% | 12.524% | -50.567% | -30.049% | -38.039% | - |
| Alkermes plc | 0.000% | 2.703% | -6.557% | -6.557% | -18.571% | -8.818% | 49.020% |
| Ironwood Pharmaceuticals | -0.750% | -4.317% | 7.258% | -88.824% | -84.167% | -93.877% | -91.419% |
| Novocure Ltd | -1.820% | -4.488% | -35.166% | -48.419% | -66.380% | -86.308% | -85.117% |
Comments
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Mizuho from $173.00 to $225.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at UBS Group AG from $170.00 to $240.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
News
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
According to an SEC filing dated July 2, 2025, LVM Capital Management reduced its position in ICON Public Limited (NASDAQ:ICLR) by selling 16,096 shares. The transaction was valued at $2.58 million
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025